{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:23:24Z","timestamp":1758637404786,"version":"3.38.0"},"reference-count":48,"publisher":"American Veterinary Medical Association (AVMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ajvr"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:p><jats:bold>Objective<\/jats:bold>\u2014To determine the mean telomere restriction fragment (TRF) length in normal and neoplastic canine tissues.<\/jats:p>\n<jats:p><jats:bold>Sample Population<\/jats:bold>\u201457 solid-tissue tumor specimens collected from client-owned dogs, 40 samples of normal tissue collected from 12 clinically normal dogs, and blood samples collected from 4 healthy blood donor dogs.<\/jats:p>\n<jats:p><jats:bold>Procedures<\/jats:bold>\u2014Tumor specimens were collected from client-owned dogs during diagnostic or therapeutic procedures at the University of Illinois Veterinary Medical Teaching Hospital, whereas 40 normal tissue samples were collected from 12 control dogs. Telomere restriction fragment length was determined by use of an assay kit. A histologic diagnosis was provided for each tumor by personnel at the Veterinary Diagnostic Laboratory at the University of Illinois.<\/jats:p>\n<jats:p><jats:bold>Results<\/jats:bold>\u2014Mean of the mean TRF length for 44 normal samples was 19.0 kilobases (kb; range, 15.4 to 21.4 kb), and the mean of the mean TRF length for 57 malignant tumors was 19.0 kb (range, 12.9 to 23.5 kb). Although the mean of the mean TRF length for tumors and normal tissues was identical, tumor samples had more variability in TRF length.<\/jats:p>\n<jats:p><jats:bold>Conclusions and Clinical Relevance<\/jats:bold>\u2014Telomerase, which represents the main mechanism by which cancer cells achieve immortality, is an attractive therapeutic target. The ability to measure telomere length is crucial to monitoring the efficacy of telomerase inhibition. In contrast to many other mammalian species, the length of canine telomeres and the rate of telomeric DNA loss are similar to those reported in humans, making dogs a compelling choice for use in the study of human antitelomerase strategies.<\/jats:p>","DOI":"10.2460\/ajvr.68.12.1386","type":"journal-article","created":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T14:16:45Z","timestamp":1196518605000},"page":"1386-1391","source":"Crossref","is-referenced-by-count":10,"title":["Telomere length in normal and neoplastic canine tissues"],"prefix":"10.2460","volume":"68","author":[{"given":"Casey D.","family":"Cadile","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara E.","family":"Kitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca G.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara J.","family":"Biller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth R.","family":"Hetler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1272","reference":[{"key":"ref1","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"6622","DOI":"10.1073\/pnas.85.18.6622","article-title":"A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the end of human chromosomes","volume":"85","author":"Moyzis","year":"1988"},{"key":"ref2","series-title":"Chromosoma","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s004120050354","article-title":"Telomeres and telomerase: more than the end of the line","volume":"108","author":"Pardue","year":"1999"},{"key":"ref3","series-title":"Oncogene","first-page":"532","article-title":"Protection of mammalian telomeres","volume":"41","author":"de Lange","year":"2002"},{"key":"ref4","series-title":"Nat Rev Drug Discov","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrd2081","article-title":"Telomerase therapeutics for cancer: challenges and new directions","volume":"5","author":"Shay","year":"2006"},{"key":"ref5","series-title":"Mutat Res","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0165-1110(96)90006-8","article-title":"The roles of telomeres and telomerase in cell life span","volume":"366","author":"Counter","year":"1996"},{"key":"ref6","series-title":"Exp Cell Res","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1006\/excr.1995.1213","article-title":"Evidence for a critical telomere length in senescent human fibroblasts","volume":"219","author":"Allsopp","year":"1995"},{"key":"ref7","series-title":"Cell","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0092-8674(00)80932-0","article-title":"TRF2 protects human telomeres from end-to-end fusions","volume":"92","author":"van Steensel","year":"1998"},{"key":"ref8","series-title":"Cell","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0092-8674(01)00504-9","article-title":"The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability","volume":"107","author":"Hemann","year":"2001"},{"key":"ref9","series-title":"Mutat Res","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0921-8734(91)90018-7","article-title":"Telomere loss: mitotic clock or genetic time bomb?","volume":"256","author":"Harley","year":"1991"},{"key":"ref10","series-title":"Curr Opin Cell Biol","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ceb.2006.03.003","article-title":"Telomerase regulation and stem cell behavior","volume":"18","author":"Flores","year":"2006"},{"key":"ref11","series-title":"EMBO J","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/sj.emboj.7600598","article-title":"Mice with bad ends: mouse models for the study of telomeres and telomerase in cancer and aging","volume":"24","author":"Blasco","year":"2005"},{"key":"ref12","series-title":"Cell","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/0092-8674(85)90170-9","article-title":"Identification of a specific telomere terminal transferase activity in Tetrahymena extracts","volume":"43","author":"Greider","year":"1985"},{"key":"ref13","series-title":"J Virol","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1128\/jvi.68.5.3410-3414.1994","article-title":"Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus transformed human B lymphocytes","volume":"68","author":"Counter","year":"1994"},{"key":"ref14","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"12606","DOI":"10.1073\/pnas.182407599","article-title":"Telomerase contributes to tumorigenesis by a telomere length-independent mechanism","volume":"99","author":"Stewart","year":"2002"},{"key":"ref15","series-title":"J Neurosci Res","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/1097-4547(20010101)63:1<1::AID-JNR1>3.0.CO;2-I","article-title":"Emerging roles for telomerase in neuronal development and apoptosis","volume":"63","author":"Mattson","year":"2001"},{"key":"ref16","series-title":"J Biol Chem","first-page":"36671","article-title":"NF-\u03baB regulates transcription of the mouse telomerase catalytic subunit","volume":"275","author":"Yin","year":"2001"},{"key":"ref17","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1038\/sj.onc.1209487","article-title":"hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway","volume":"25","author":"Massard","year":"2006"},{"key":"ref18","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.1074\/jbc.274.11.7264","article-title":"Anti-apoptotic role of telomerase in pheochromocytoma cells","volume":"274","author":"Fu","year":"1999"},{"key":"ref19","series-title":"Cancer Res","first-page":"18","article-title":"Nuclear factor-\u03baB p65 mediates tumor necrosis factor A-induced nuclear translocation of telomerase reverse transcriptase protein","volume":"63","author":"Akiyama","year":"2003"},{"key":"ref20","series-title":"Science","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1126\/science.7605428","article-title":"Specific associations of human telomerase activity with immortal cells and cancer","volume":"266","author":"Kim","year":"1994"},{"key":"ref21","series-title":"Eur J Cancer","first-page":"787","article-title":"A survey of telomerase activity in human cancer","volume":"5","author":"Shay","year":"1997"},{"key":"ref22","series-title":"Annu Rev Cell Dev Biol","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.cellbio.22.010305.104518","article-title":"Telomeres: cancer to human aging","volume":"22","author":"Stewart","year":"2006"},{"key":"ref23","series-title":"Am J Vet Res","first-page":"1526","article-title":"Evaluation of an assay for detecting telomerase activity in neoplastic tissues of dogs","volume":"59","author":"Biller","year":"1998"},{"key":"ref24","series-title":"J Vet Med Sci","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1292\/jvms.61.1125","article-title":"Measurement of telomerase activity in dog tumors","volume":"61","author":"Yazawa","year":"1999"},{"key":"ref25","series-title":"Vet Pathol","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1354\/vp.37-2-177","article-title":"Cellular proliferative and telomerase activity in canine mammary gland tumors","volume":"37","author":"Funakoshi","year":"2000"},{"key":"ref26","series-title":"Am J Vet Res","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.2460\/ajvr.2001.62.1539","article-title":"Telomere length and telomerase activity in canine mammary gland tumors","volume":"62","author":"Yazawa","year":"2001"},{"key":"ref27","series-title":"Vet Pathol","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1354\/vp.40-1-1","article-title":"Telomerase: a potential diagnostic and therapeutic tool in canine oncology","volume":"40","author":"Argyle","year":"2003"},{"key":"ref28","series-title":"Vet Comp Oncol","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1476-5829.2006.00106.x","article-title":"Telomerase activity in canine osteosarcoma","volume":"4","author":"Kow","year":"2006"},{"key":"ref29","series-title":"Vet Comp Oncol","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1476-5829.2006.00103.x","article-title":"Telomerase activity and telomerase reverse transcriptase catalytic subunit expression in canine lymphoma: correlation with Ki67 immunoreactivity","volume":"4","author":"Renwick","year":"2006"},{"key":"ref30","series-title":"Exp Cell Res","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1006\/excr.1998.4102","article-title":"Change in telomerase activity of rat organs during growth and aging","volume":"242","author":"Yamaguchi","year":"1998"},{"key":"ref31","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"9078","DOI":"10.1073\/pnas.95.16.9078","article-title":"Can the ends justify the means? Telomeres and the mechanisms of replicative senescence in mammalian cells","volume":"95","author":"Sedivy","year":"1998"},{"key":"ref32","series-title":"Vet Comp Oncol","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1476-5829.2003.00019.x","article-title":"Telomerase activity and related properties of normal canine lymph node and canine lymphoma","volume":"1","author":"Hipple","year":"2003"},{"key":"ref33","series-title":"J Nutr","doi-asserted-by":"publisher","first-page":"1604S","DOI":"10.1093\/jn\/132.6.1604S","article-title":"Telomere lengths in dogs decrease with increasing donor age","volume":"132","author":"McKevitt","year":"2002"},{"key":"ref34","series-title":"Neoplasia","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/sj.neo.7900173","article-title":"Telomere lengths and telomerase activity in dog tissues: a potential model system to study human telomere and telomerase biology","volume":"3","author":"Nasir","year":"2001"},{"key":"ref35","series-title":"Nature","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/345458a0","article-title":"Telomeres shorten during ageing of human fibroblasts","volume":"345","author":"Harley","year":"1990"},{"key":"ref36","series-title":"Proc Soc Exp Biol Med","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1046\/j.1525-1373.2000.22354.x","article-title":"Clonal heterogeneity in telomerase activity and telomere length in tumor-derived cell lines","volume":"223","author":"Savre-Train","year":"2000"},{"key":"ref37","series-title":"EMBO J","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1002\/j.1460-2075.1995.tb00098.x","article-title":"Telomere elongation in immortal human cells without detectable telomerase activity","volume":"14","author":"Bryan","year":"1995"},{"key":"ref38","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/sj.onc.1205058","article-title":"Alternative lengthening of telomeres in mammalian cells","volume":"21","author":"Henson","year":"2002"},{"key":"ref39","series-title":"Cancer Res","first-page":"1759","article-title":"Absence of telomere maintenance mechanism as a favourable prognostic factor in patients with osteosarcoma","volume":"63","author":"Ulaner","year":"2003"},{"key":"ref40","series-title":"Mol Cell Biol","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.1128\/MCB.21.12.3862-3875.2001","article-title":"Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells","volume":"21","author":"Perrem","year":"2001"},{"key":"ref41","series-title":"Nucleic Acids Res","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1093\/nar\/26.16.3651","article-title":"Telomere analysis by fluorescence in situ hybridization and flow cytometry","volume":"26","author":"Hultdin","year":"1998"},{"key":"ref42","series-title":"Cytogenet Cell Genet","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000133804","article-title":"Evidence that metacentric and submetacentric chromosomes in canine tumors can result from telomeric fusions","volume":"67","author":"Reimann","year":"1994"},{"key":"ref43","series-title":"Curr Med Chem","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.2174\/092986705774933416","article-title":"Telomerase inhibition and cancer: might platinum based drugs have a future as anti-telomerase pharmacological approach?","volume":"12","author":"Colangelo","year":"2005"},{"key":"ref44","series-title":"Biometals","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1023\/A:1023428315746","article-title":"Cis-[Pt(Cl)2(pyridine)(5SO3H-isoquinoline)] complex, a selective inhibitor of telomerase enzyme","volume":"16","author":"Colangelo","year":"2003"},{"key":"ref45","series-title":"Eur J Obstet Gynec Reprod Biol","first-page":"249","article-title":"The telomerase activity and expression of hTERT gene can serve as indicators in the anticancer treatment of human ovarian cancer","volume":"130","author":"Sun","year":"2005"},{"key":"ref46","series-title":"Clin Cancer Res","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1158\/1078-0432.CCR-0793-03","article-title":"Telomerase inhibition and cell growth arrest after telomestatin treatment in multiple myeloma","volume":"10","author":"Shammas","year":"2004"},{"key":"ref47","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1038\/sj.onc.1209217","article-title":"G-quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by the loss of the 3\u2032 overhang in cancer cells","volume":"25","author":"Tahara","year":"2006"},{"key":"ref48","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"8191","DOI":"10.1073\/pnas.112515399","article-title":"Constitutive telomerase expression promotes mammary carcinomas in mice","volume":"99","author":"Artandi","year":"2002"}],"container-title":["American Journal of Veterinary Research"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/68\/12\/ajvr.68.12.1386.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/68\/12\/ajvr.68.12.1386.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/68\/12\/ajvr.68.12.1386.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:15:48Z","timestamp":1741349748000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/68\/12\/ajvr.68.12.1386.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":48,"journal-issue":{"issue":"12"},"URL":"https:\/\/doi.org\/10.2460\/ajvr.68.12.1386","relation":{},"ISSN":["0002-9645"],"issn-type":[{"type":"print","value":"0002-9645"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}